Cite
HARVARD Citation
Rodolakis, I. et al. (n.d.). 2022-RA-1453-ESGO Chemotherapy response score as a predictor of survival among patients undergoing interval debulking surgery for ovarian cancer. International journal of gynecological cancer. p. A338. [Online].